P98156 (VLDLR_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 131.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Very low-density lipoprotein receptor Short name=VLDL receptor Short name=VLDL-R | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 873 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. Binding to Reelin induces tyrosine phosphorylation of Dab1 and modulation of Tau phosphorylation. |
| Subunit structure | Binds to the extracellular matrix protein Reelin. Interacts with DAB1. Interacts with VLDLR. Interacts with SNX17. Interacts with PCSK9 By similarity. Ref.4 Ref.5 Ref.6 |
| Subcellular location | Membrane; Single-pass type I membrane protein. Membrane › clathrin-coated pit; Single-pass type I membrane protein. |
| Tissue specificity | Abundant in heart and muscle; less in kidney, brain, ovary, testis, lung and adipose tissue. |
| Post-translational modification | Ubiquitinated at Lys-839 by MYLIP leading to degradation By similarity. Ref.7 |
| Miscellaneous | LRP8 and VLVLR together are required for correct embryonic development in the brain. Targeted disruption of both genes results in a phenotype virtually indistinguishable from that seen in "reeler" and "scrambler" mice. Subtle effects of VLDLR deletion are found mainly in the cerebellum, whereas lack of LRP8 predominantly affects the positioning of the neurons in the neocortex. |
| Sequence similarities | Contains 3 EGF-like domains. Contains 8 LDL-receptor class A domains. Contains 6 LDL-receptor class B repeats. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 27 | 27 | Potential | ||||||||
| Chain | 28 – 873 | 846 | Very low-density lipoprotein receptor | PRO_0000017344 | |||||||
Regions | |||||||||||
| Topological domain | 28 – 797 | 770 | Extracellular Potential | ||||||||
| Transmembrane | 798 – 819 | 22 | Helical; Potential | ||||||||
| Topological domain | 820 – 873 | 54 | Cytoplasmic Potential | ||||||||
| Domain | 31 – 69 | 39 | LDL-receptor class A 1 | ||||||||
| Domain | 70 – 110 | 41 | LDL-receptor class A 2 | ||||||||
| Domain | 111 – 151 | 41 | LDL-receptor class A 3 | ||||||||
| Domain | 152 – 190 | 39 | LDL-receptor class A 4 | ||||||||
| Domain | 191 – 231 | 41 | LDL-receptor class A 5 | ||||||||
| Domain | 237 – 275 | 39 | LDL-receptor class A 6 | ||||||||
| Domain | 276 – 314 | 39 | LDL-receptor class A 7 | ||||||||
| Domain | 316 – 355 | 40 | LDL-receptor class A 8 | ||||||||
| Domain | 356 – 391 | 36 | EGF-like 1 | ||||||||
| Domain | 396 – 431 | 36 | EGF-like 2; calcium-binding Potential | ||||||||
| Repeat | 439 – 480 | 42 | LDL-receptor class B 1 | ||||||||
| Repeat | 481 – 524 | 44 | LDL-receptor class B 2 | ||||||||
| Repeat | 525 – 567 | 43 | LDL-receptor class B 3 | ||||||||
| Repeat | 568 – 611 | 44 | LDL-receptor class B 4 | ||||||||
| Repeat | 612 – 654 | 43 | LDL-receptor class B 5 | ||||||||
| Repeat | 655 – 697 | 43 | LDL-receptor class B 6 | ||||||||
| Domain | 702 – 750 | 49 | EGF-like 3 | ||||||||
| Region | 751 – 790 | 40 | Clustered O-linked oligosaccharides | ||||||||
| Motif | 832 – 837 | 6 | Endocytosis signal Potential | ||||||||
Amino acid modifications | |||||||||||
| Glycosylation | 151 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 765 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 781 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 33 ↔ 45 | By similarity | |||||||||
| Disulfide bond | 40 ↔ 58 | By similarity | |||||||||
| Disulfide bond | 52 ↔ 67 | By similarity | |||||||||
| Disulfide bond | 72 ↔ 84 | By similarity | |||||||||
| Disulfide bond | 79 ↔ 97 | By similarity | |||||||||
| Disulfide bond | 91 ↔ 108 | By similarity | |||||||||
| Disulfide bond | 113 ↔ 127 | By similarity | |||||||||
| Disulfide bond | 120 ↔ 140 | By similarity | |||||||||
| Disulfide bond | 134 ↔ 149 | By similarity | |||||||||
| Disulfide bond | 154 ↔ 166 | By similarity | |||||||||
| Disulfide bond | 161 ↔ 179 | By similarity | |||||||||
| Disulfide bond | 173 ↔ 188 | By similarity | |||||||||
| Disulfide bond | 193 ↔ 205 | By similarity | |||||||||
| Disulfide bond | 200 ↔ 218 | By similarity | |||||||||
| Disulfide bond | 212 ↔ 229 | By similarity | |||||||||
| Disulfide bond | 239 ↔ 251 | By similarity | |||||||||
| Disulfide bond | 246 ↔ 264 | By similarity | |||||||||
| Disulfide bond | 258 ↔ 273 | By similarity | |||||||||
| Disulfide bond | 278 ↔ 290 | By similarity | |||||||||
| Disulfide bond | 285 ↔ 303 | By similarity | |||||||||
| Disulfide bond | 297 ↔ 312 | By similarity | |||||||||
| Disulfide bond | 318 ↔ 331 | By similarity | |||||||||
| Disulfide bond | 326 ↔ 344 | By similarity | |||||||||
| Disulfide bond | 338 ↔ 355 | By similarity | |||||||||
| Disulfide bond | 360 ↔ 371 | By similarity | |||||||||
| Disulfide bond | 367 ↔ 380 | By similarity | |||||||||
| Disulfide bond | 382 ↔ 394 | By similarity | |||||||||
| Disulfide bond | 400 ↔ 410 | By similarity | |||||||||
| Disulfide bond | 406 ↔ 419 | By similarity | |||||||||
| Disulfide bond | 421 ↔ 434 | By similarity | |||||||||
| Disulfide bond | 706 ↔ 719 | By similarity | |||||||||
| Disulfide bond | 715 ↔ 734 | By similarity | |||||||||
| Disulfide bond | 736 ↔ 749 | By similarity | |||||||||
| Cross-link | 839 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||||
Experimental info | |||||||||||
| Sequence conflict | 161 | 1 | C → G in AAC37668. Ref.1 | ||||||||
| Sequence conflict | 262 | 1 | P → L in AAB32228. Ref.3 | ||||||||
| Sequence conflict | 297 | 1 | C → S in AAA59384. Ref.2 | ||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor." Oka K., Ishimura-Oka K., Chu M.J., Sullivan M., Krushkal J., Li W.H., Chan L. Eur. J. Biochem. 224:975-982(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Strain: BALB/c. Tissue: Heart. |
| [2] | "Cloning of a complementary deoxyribonucleic acid encoding the murine homolog of the very low density lipoprotein/apolipoprotein-E receptor: expression pattern and assignment of the gene to mouse chromosome 19." Gafvels M.E., Paavola L.G., Boyd C.O., Nolan P.M., Wittmaack F., Chawla A., Lazar M.A., Bucan M., Angelin B.O., Strauss J.F. Endocrinology 135:387-394(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Skeletal muscle. |
| [3] | "The mouse very low density lipoprotein receptor (Vldlr) gene maps to chromosome 19." Naggert J.K., Mu J.L. Mamm. Genome 5:453-455(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 204-262. |
| [4] | "Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation." Hiesberger T., Trommsdorff M., Howell B.W., Goffinet A.M., Mumby M.C., Cooper J.A., Herz J. Neuron 24:481-489(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH REELIN. |
| [5] | "The PX-domain protein SNX17 interacts with members of the LDL receptor family and modulates endocytosis of the LDL receptor." Stockinger W., Sailler B., Strasser V., Recheis B., Fasching D., Kahr L., Schneider W.J., Nimpf J. EMBO J. 21:4259-4267(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SNX17. |
| [6] | "Normal sorting but defective endocytosis of the low density lipoprotein receptor in mice with autosomal recessive hypercholesterolemia." Jones C., Hammer R.E., Li W.-P., Cohen J.C., Hobbs H.H., Herz J. J. Biol. Chem. 278:29024-29030(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH LDLRAP1. |
| [7] | "The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2." Hong C., Duit S., Jalonen P., Out R., Scheer L., Sorrentino V., Boyadjian R., Rodenburg K.W., Foley E., Korhonen L., Lindholm D., Nimpf J., van Berkel T.J., Tontonoz P., Zelcer N. J. Biol. Chem. 285:19720-19726(2010) [PubMed] [Europe PMC] [Abstract] Cited for: UBIQUITINATION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | L33417 mRNA. Translation: AAC37668.1. U06670 mRNA. Translation: AAA59384.1. S73732 Genomic DNA. Translation: AAB32228.2. |
| IPI | IPI00323114. |
| PIR | I48952. |
| RefSeq | NP_001154892.1. NM_001161420.1. NP_038731.2. NM_013703.2. |
| UniGene | Mm.4141. |
3D structure databases | |
| ProteinModelPortal | P98156. |
| SMR | P98156. Positions 21-789. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-33283N. |
| IntAct | P98156. 1 interaction. |
Proteomic databases | |
| PaxDb | P98156. |
| PRIDE | P98156. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000167487; ENSMUSP00000127329; ENSMUSG00000024924. |
| GeneID | 22359. |
| KEGG | mmu:22359. |
| UCSC | uc008hbt.2. mouse. |
Organism-specific databases | |
| CTD | 7436. |
| MGI | MGI:98935. Vldlr. |
Phylogenomic databases | |
| eggNOG | NOG255913. |
| GeneTree | ENSGT00700000104037. |
| HOGENOM | HOG000115656. |
| HOVERGEN | HBG006250. |
| InParanoid | P98156. |
| OMA | SIDIGRH. |
Gene expression databases | |
| ArrayExpress | P98156. |
| Bgee | P98156. |
| CleanEx | MM_VLDLR. |
| Genevestigator | P98156. |
| GermOnline | ENSMUSG00000024924. Mus musculus. |
Family and domain databases | |
| Gene3D | 2.120.10.30. 1 hit. 4.10.400.10. 8 hits. |
| InterPro | IPR011042. 6-blade_b-propeller_TolB-like. IPR000742. EG-like_dom. IPR001881. EGF-like_Ca-bd. IPR013032. EGF-like_CS. IPR000152. EGF-type_Asp/Asn_hydroxyl_site. IPR018097. EGF_Ca-bd_CS. IPR009030. Growth_fac_rcpt. IPR023415. LDLR_class-A_CS. IPR000033. LDLR_classB_rpt. IPR002172. LDrepeatLR_classA_rpt. [Graphical view] |
| Pfam | PF07645. EGF_CA. 1 hit. PF00057. Ldl_recept_a. 8 hits. PF00058. Ldl_recept_b. 5 hits. [Graphical view] |
| SMART | SM00181. EGF. 1 hit. SM00179. EGF_CA. 2 hits. SM00192. LDLa. 8 hits. SM00135. LY. 5 hits. [Graphical view] |
| SUPFAM | SSF57184. Grow_fac_recept. 1 hit. SSF57424. LDL_rcpt_classA_cys-rich. 8 hits. |
| PROSITE | PS00010. ASX_HYDROXYL. 2 hits. PS00022. EGF_1. False negative. PS01186. EGF_2. 3 hits. PS50026. EGF_3. 2 hits. PS01187. EGF_CA. 1 hit. PS01209. LDLRA_1. 8 hits. PS50068. LDLRA_2. 8 hits. PS51120. LDLRB. 5 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 302661. |
| SOURCE | Search... |
Entry information
| Entry name | VLDLR_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P98156 Secondary accession number(s): Q64022 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
